Sequential Combination of Paclitaxel-Carboplatin and Paclitaxel-Liposomal Doxorubicin as a First-Line Treatment in Patients with Ovarian Cancer

Publisher： Karger

E-ISSN： 1423-0232|69|4|348-353

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.4, 2005-12, pp. : 348-353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose Finding Study for Combination Treatment with Topotecan and Gemcitabine of Patients with Recurrent Ovarian Cancer after Failure of First-Line Chemotherapy with Paclitaxel and Platinum

By  

Oncology Research and Treatment, Vol. 27, Iss. 1, 2004-03 ,pp. : 58-64

Karger

Access to resources Recommend Favorite

Paclitaxel/carboplatin with or without belinostat as empiric first‐line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial

By  

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1654-1661

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nilotinib in Combination with Carboplatin and Paclitaxel Is a Candidate for Ovarian Cancer Treatment

By  

Oncology, Vol. 87, Iss. 4, 2014-08 ,pp. : 232-245

Karger

Access to resources Recommend Favorite

Multicenter Phase II Study of Pegylated Liposomal Doxorubicin in Combination with Vinorelbine as First-Line Treatment in Elderly Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 1-2, 2009-01 ,pp. : 18-24

Karger

Access to resources Recommend Favorite

Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer

By Sherrill Beth   Di Leo Angelo   Amonkar Mayur M.   Wu Yun   Zvirbule Zanete   Aziz Zeba   Bines Jose   Gomez Henry L.  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 767-775

Informa Healthcare

Access to resources Recommend Favorite